Back to top

Array BioPharma (ARRY) Looks Good: Stock Adds 5.9% in Session
August 24, 2017

Read MoreHide Full Article

Array BioPharma Inc. (ARRY - Free Report) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 22.3% in the past one-month time frame.

The company’s Zacks Consensus Estimate for the current quarter has moved lower over the past few weeks, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Array BioPharma currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Investors interested in the Medical - Biomedical and Genetics industry may consider Alexion Pharmaceuticals, Inc. (ALXN - Free Report) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is ARRY going up? Or down? Predict to see what others think: Up or Down

One Simple Trading Idea

Since 1988, the Zacks system has more than doubled the S&P 500 with an average gain of +25% per year. With compounding, rebalancing, and exclusive of fees, it can turn thousands into millions of dollars.

This proven stock-picking system is grounded on a single big idea that can be fortune shaping and life changing. You can apply it to your portfolio starting today.

Learn more >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Alexion Pharmaceuticals, Inc. (ALXN) - free report >>

Array BioPharma Inc. (ARRY) - free report >>


More from Zacks Tale of the Tape

You May Like